Stock Information
C4 Therapeutics, Inc (CCCC)
Ticker Symbol: CCCC
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $437.85 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.1839
Revenue (TTM): $0.28 M
Dividend Yield: N/A%
ROE: -50.68%
Latest News
-
C4 Therapeutics "Buy" On Cemsidomide Advancement And Competitor's Positive Readout
Tue, Jun 2, 2026 10:58 AM
-
Evercore ISI Group Maintains Outperform on C4 Therapeutics, Raises Price Target to $12
Mon, Jun 1, 2026 12:36 PM
-
12 Health Care Stocks Moving In Friday's Intraday Session
Fri, May 29, 2026 1:06 PM
Key Financials
Financial data not available
